Actionable news
All posts from Actionable news
Actionable news in BIIB: Biogen Idec Inc.,

Today's Pre-Market Trading Very Positive For Biogen (BIIB)

Trade-Ideas LLC identified Biogen ( BIIB) as a pre-market leader candidate. In addition to specific proprietary factors, Trade-Ideas identified Biogen as such a stock due to the following factors:

  • BIIB has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $975.4 million.
  • BIIB traded 12,692 shares today in the pre-market hours as of 8:01 AM.
  • BIIB is up 7.6% today from yesterday's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in BIIB with the Ticky from Trade-Ideas. See the FREE profile for BIIB NOW at Trade-Ideas More details on BIIB: Biogen Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. BIIB has a PE ratio of 18. Currently there are 14 analysts that rate Biogen a buy, no analysts rate it a sell, and 8 rate it a hold. The average volume for Biogen has been 3.1 million shares per day over the past 30 days. Biogen has a market cap of $64.1 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.63 and a...